Literature DB >> 19798759

Generalized anxiety disorder within the course of major depressive disorder: examining the utility of the DSM-IV hierarchy rule.

Amy E Lawrence1, Gabrielle I Liverant, Anthony J Rosellini, Timothy A Brown.   

Abstract

BACKGROUND: The current Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) specifies that generalized anxiety disorder (GAD) should not be diagnosed if it occurs exclusively during an episode of a major depressive disorder (MDD) or another mood disorder. This hierarchy rule was intended to promote diagnostic parsimony, but may result in the loss of important clinical information. The goal of this study was to compare individuals with MDD, comorbid MDD and GAD, and GAD within the course of MDD at intake and 12-month follow-up on self-report measures, clinician ratings, and rates of comorbidity.
METHODS: Participants were divided into three diagnostic groups: MDD without GAD (n=124), comorbid MDD and GAD (n=59), and GAD within the course of MDD (n=166). All the participants completed a semi-structured clinical interview and self-report measures assessing psychopathology, temperament, and functional impairment. A subset of the total sample completed a follow-up assessment of 12 months postintake.
RESULTS: Individuals with comorbid MDD and GAD and GAD within the course of MDD reported more psychopathology, negative affect, and functional impairment at intake than individuals with MDD only. The presence of GAD at intake, however, did not differentially predict symptom severity, functional impairment, or the presence of comorbidity at 12-month follow-up.
CONCLUSIONS: Cross-sectional findings indicate that individuals with GAD within the course of MDD experience levels of psychopathology, functional impairment, and comorbidity similar to those found in individuals with comorbid GAD and MDD. Preliminary longitudinal findings, however, suggest that the presence of GAD in patients with MDD does not have prognostic significance.

Entities:  

Mesh:

Year:  2009        PMID: 19798759      PMCID: PMC5639477          DOI: 10.1002/da.20607

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  34 in total

1.  Confirmatory factor analysis of the Penn State Worry Questionnaire: Multiple factors or method effects?

Authors:  Timothy A Brown
Journal:  Behav Res Ther       Date:  2003-12

2.  Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Deborah S Hasin; Frederick S Stinson; Deborah A Dawson; W June Ruan; Risë B Goldstein; Sharon M Smith; Tulshi D Saha; Boji Huang
Journal:  Psychol Med       Date:  2005-10-05       Impact factor: 7.723

3.  Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment.

Authors:  T A Brown; D H Barlow
Journal:  J Consult Clin Psychol       Date:  1995-10

4.  Major depression and generalised anxiety disorder. Same genes, (partly)different environments--revisited.

Authors:  K S Kendler
Journal:  Br J Psychiatry Suppl       Date:  1996-06

5.  Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal.

Authors:  T A Brown; B F Chorpita; D H Barlow
Journal:  J Abnorm Psychol       Date:  1998-05

6.  Treatment resistant depression and axis I co-morbidity.

Authors:  T Petersen; J A Gordon; A Kant; M Fava; J F Rosenbaum; A A Nierenberg
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

7.  Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Authors:  T A Brown; L A Campbell; C L Lehman; J R Grisham; R B Mancill
Journal:  J Abnorm Psychol       Date:  2001-11

8.  Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnoses following treatment.

Authors:  T A Brown; M M Antony; D H Barlow
Journal:  J Consult Clin Psychol       Date:  1995-06

9.  Behavioral activation and inhibition systems and the severity and course of depression.

Authors:  Karen L Kasch; Jonathan Rottenberg; Bruce A Arnow; Ian H Gotlib
Journal:  J Abnorm Psychol       Date:  2002-11

10.  Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

Authors:  K S Kendler; M C Neale; R C Kessler; A C Heath; L J Eaves
Journal:  Arch Gen Psychiatry       Date:  1992-09
View more
  10 in total

1.  Rumination and Worry in Daily Life: Examining the Naturalistic Validity of Theoretical Constructs.

Authors:  Katharina Kircanski; Renee J Thompson; James Sorenson; Lindsey Sherdell; Ian H Gotlib
Journal:  Clin Psychol Sci       Date:  2015-04-02

2.  The everyday dynamics of rumination and worry: precipitant events and affective consequences.

Authors:  Katharina Kircanski; Renee J Thompson; James Sorenson; Lindsey Sherdell; Ian H Gotlib
Journal:  Cogn Emot       Date:  2017-01-20

3.  Neurobiological signatures of anxiety and depression in resting-state functional magnetic resonance imaging.

Authors:  Desmond J Oathes; Brian Patenaude; Alan F Schatzberg; Amit Etkin
Journal:  Biol Psychiatry       Date:  2014-08-15       Impact factor: 13.382

4.  Changes in anxiety and depression over 2 years in medically stable patients after myocardial infarction and their spouses in the Home Automatic External Defibrillator Trial (HAT): a longitudinal observational study.

Authors:  Sue A Thomas; Erika Friedmann; Hyeon-Joo Lee; Heesook Son; Patricia G Morton
Journal:  Heart       Date:  2010-10-07       Impact factor: 5.994

5.  A case of paroxetine-induced galactorrhoea with normal serum prolactin level.

Authors:  Suddhendu Chakraborty; Debasish Sanyal; Ranjan Bhattacharyya; Subhendu Dutta
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

6.  Diagnostic and symptom-based predictors of emotional processing in generalized anxiety disorder and major depressive disorder: An event-related potential study.

Authors:  Annmarie MacNamara; Roman Kotov; Greg Hajcak
Journal:  Cognit Ther Res       Date:  2015-08-30

Review 7.  A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment.

Authors:  Timothy A Brown; David H Barlow
Journal:  Psychol Assess       Date:  2009-09

8.  Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe.

Authors:  Ayelet Meron Ruscio; Lauren S Hallion; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura Helena Andrade; Guilherme Borges; Evelyn J Bromet; Brendan Bunting; José Miguel Caldas de Almeida; Koen Demyttenaere; Silvia Florescu; Giovanni de Girolamo; Oye Gureje; Josep Maria Haro; Yanling He; Hristo Hinkov; Chiyi Hu; Peter de Jonge; Elie G Karam; Sing Lee; Jean-Pierre Lepine; Daphna Levinson; Zeina Mneimneh; Fernando Navarro-Mateu; José Posada-Villa; Tim Slade; Dan J Stein; Yolanda Torres; Hidenori Uda; Bogdan Wojtyniak; Ronald C Kessler; Somnath Chatterji; Kate M Scott
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

9.  Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample.

Authors:  Jude U Ohaeri; Abdel W Awadalla
Journal:  Med Sci Monit       Date:  2012-03

10.  The Neurobiological Mechanisms of Generalized Anxiety Disorder and Chronic Stress.

Authors:  Michelle A Patriquin; Sanjay J Mathew
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.